-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $104

Benzinga·08/21/2026 16:46:39
Listen to the news
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $108 to $104.